AlphaRose Therapeutics
- Biotech or pharma, therapeutic R&D
AlphaRose Therapeutics is an antisense oligonucleotide platform that focuses on developing and commercializing small population genetic treatments for rare genetic diseases, particularly targeting children. We are creating a scalable precision medicine model, utilizing programmable genetic medicines, AI, and other advanced technologies, to make treatments accessible and affordable for millions of patients worldwide. Our mission is to accelerate development and commercialization, revolutionizing access to personalized genetic therapies, starting with children who need them most.